FDA Investigator Dauksism
Dauksism has conducted inspections on 150 sites in 1 countries as of 29 Sep 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
150
Last Inspection Date:
29 Sep 2011
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Dauksism:
Abdellah El Hajjam,
Addie V Scott Boston,
Alan D Centi,
Anastasia M Shields,
Anita R Michael,
Ann Marie Karnick,
Audrey Thereset Uy,
Brandi L Garbutt,
Brandon J Brookens,
Brandon M Kurjanowicz,
Brian D Young,
Brian M Palermo,
Brian S Keefer,
Calvin W Edwards,
Cara M Minelli,
Carl E Lovrich,
CDR Michael J Mero,
Celia L Hutchinstein,
Chamberlain,
Crystal A Harlan,
Cynthia L Rakestraw,
Daniel J Mechenbier,
Daniel R Tammariello,
Daniel W Johnson,
David A Schwartz,
David L Pearce,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Dennis R Hock,
Derek S Dealy,
Dessa A Antoine,
Dr. Mark J Seaton, PhD,
Edward D Mcdonald,
Edwin L Hobbs,
Eric S Myskowski,
Erica L Nicoll,
Erik A Bungo,
Erika M Wilkerson,
Gayle S Lawson,
Gerald W Kopp,
Gladys B Casper,
Gregory E Beichner,
James M Mason,
James M Odonnell,
James P Mcevoy,
Jeannie R Mayberry,
Joseph Brady,
Joseph R Hatcher,
Joseph S Fanelli,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Paterson,
Julianne C Mccullough,
Karen A Spencer,
Katelyn Astaub Zamperini,
Kelly N Kerr,
Kendra L Brooks,
Kirk A Dymbrowski,
Kristen D Evans,
Kristina J Donohue,
Kyle D Covill,
Kyle S Hobson,
LCDR Margaret Edi Gennaro,
LCDR William H Bender,
Lisa B Orr,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Magda M Karlsen,
Marc A Jackson, Jr,
Marjorie L Davis,
Martha Sullivan Myrick,
Mary E Storch,
Mary R Kirker,
Matthew R Noonan,
Maureen A Duckworth,
Maureen A Wentzel,
Melissa M Dauksis,
Melissa M Schafer,
Michael A Taylor,
Michael J Nerz,
Michele M Falchek,
Monali M Yajnik,
Nicholas J Morici,
Nikisha M Bolden,
O'meara,
Pamela M Tremarki,
Rahi D Patel,
Ramanda C Gregory,
Ronald A Stokes,
Ronald T Colucci,
Sarah K Lemin,
Sean D Duke,
Seng Ching Hwang,
Stephanie Mangigian, MS/OSH, RN,
Steven E Kane,
Tammy L Chavis,
Tammy M Phillips,
Tania E Vizcaino,
Thomas E Friel,
Timothy J Schmidt,
Todd J Maushart,
Tonya O Corbin,
Travis R Hunt,
Valerie G Vallely,
Van Cliff,
Whitney S Reynolds,
William A Warnick,
William C Brenneman,
Xinyi Hui,
Yessika Mashinski
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more